Literature DB >> 4993232

Lipoprotein inhibitor of Newcastle disease virus from chicken lung.

R G Allen, J T Barrett, B J Campbell.   

Abstract

A lipoprotein inhibitor of Newcastle disease virus was obtained from chicken lung tissue by means of dilute alkaline extraction procedures. The inhibitor was further purified by ammonium sulfate fractionation, isoelectric precipitation, and density gradient centrifugation. The purified lipoprotein inhibited active Newcastle disease virus hemagglutination at a concentration of 2.0 mug/ml which represented a 30-fold purification over the original extract. Infection of chicken embryo fibroblasts by Newcastle disease virus was also inhibited by the purified lipoprotein, the degree of inhibition depending upon the inhibitor-to-virus ratio. Chemical analysis of the purified inhibitor provided a composition of 72% lipid, 26% protein, and 3% carbohydrate, although some compositional variation was observed from one preparation to another. The chloroform-soluble lipids were shown to contain 40 to 50% phospholipid and 10 to 20% cholesterol; of the fatty acids recovered from the saponified lipoprotein, 39% was palmitic, 22% oleic, and 17% stearic. Careful analyses of large quantities of the inhibitor revealed a small (0.84%) but significant content of sialic acid. Removal of sialic acid from the lipoprotein by means of digestion with neuraminidase produced a sharp diminution in inhibitory properties. A delipidized form of the inhibitor was obtained by ether extraction, and this material produced a single broad band of precipitate in gel immunodiffusion tests.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4993232      PMCID: PMC377116          DOI: 10.1128/am.21.1.53-60.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  26 in total

1.  IMMUNOCHEMICAL STUDIES WITH CHYMOTRYPSINOGEN A.

Authors:  J T BARRETT; L D THOMPSON
Journal:  Immunology       Date:  1965-02       Impact factor: 7.397

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  The ribonucleic acid, lipid, and polysaccharide constituents of influenza virus preparations.

Authors:  L H FROMMHAGEN; C A KNIGHT; N K FREEMAN
Journal:  Virology       Date:  1959-06       Impact factor: 3.616

4.  Nutrition needs of mammalian cells in tissue culture.

Authors:  H EAGLE
Journal:  Science       Date:  1955-09-16       Impact factor: 47.728

5.  Inhibition of influenza virus haemagglutination by a brain lipid fraction.

Authors:  A ROSENBERG; C HOWE; E CHARGAFF
Journal:  Nature       Date:  1956-02-04       Impact factor: 49.962

6.  Preparation of lipide extracts from brain tissue.

Authors:  J FOLCH; I ASCOLI; M LEES; J A MEATH; N LeBARON
Journal:  J Biol Chem       Date:  1951-08       Impact factor: 5.157

7.  Purification and properties of an influenza virus inhibitor isolated from mouse lungs.

Authors:  M Lobodzińska; O Krizanová
Journal:  Acta Virol       Date:  1966-01       Impact factor: 1.162

8.  The proteins of the erythrocyte membrane obtained by solubilization with aqueous pyridine solution.

Authors:  O O Blumenfeld
Journal:  Biochem Biophys Res Commun       Date:  1968-01-25       Impact factor: 3.575

9.  Structural aspects of ovine alpha 1-glycoprotein, an inhibitor of Newcastle disease virus.

Authors:  B J Campbell; A L Schneider; D N Howe; D P Durand
Journal:  Biochim Biophys Acta       Date:  1967-10-09

10.  The isolation of a cell membrane fraction from rat liver.

Authors:  D M NEVILLE
Journal:  J Biophys Biochem Cytol       Date:  1960-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.